Granulocyte/macrophage-colony stimulating factor and interleukin-4 expand and activate type-1 dendritic cells (DC1) when administered in vivo to cancer patients. [electronic resource]
Producer: 20031021Description: 256-61 p. digitalISSN:- 0020-7136
- Antigens, CD -- blood
- Case-Control Studies
- Dendritic Cells -- immunology
- Granulocyte-Macrophage Colony-Stimulating Factor -- administration & dosage
- HLA-DR Antigens -- immunology
- Humans
- Immunotherapy
- Interleukin-4 -- administration & dosage
- Lymphocytes -- immunology
- Monocytes -- immunology
- Neoplasms -- blood
- Neoplastic Cells, Circulating
- Phenotype
- Recombinant Proteins
- Th2 Cells -- immunology
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.